glimepiride and fluorodeoxyglucose f18

glimepiride has been researched along with fluorodeoxyglucose f18 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Harada, H; Hayabuchi, N; Ikeda, H; Imaizumi, T; Ishibashi, M; Kaida, H; Kodama, N; Mawatari, K; Mizoguchi, M; Nitta, Y; Oba, T; Tahara, A; Tahara, N; Yamagishi, S; Yasukawa, H1
Finn, AV; Tawakol, A1
Marwick, TH; Narula, J1
Abe, T; Fukumoto, Y; Honda, A; Ikeda, H; Imaizumi, T; Ishibashi, M; Kaida, H; Kodama, N; Mizoguchi, M; Narula, J; Nitta, Y; Tahara, A; Tahara, N; Yamagishi, S1
Hayabuchi, N; Honda, A; Ikeda, H; Imaizumi, T; Ishibashi, M; Kaida, H; Kodama, N; Mizoguchi, M; Nitta, Y; Tahara, A; Tahara, N; Yamagishi, S1
Gu, B; Liu, H; Ma, J; Ma, P; Tan, B1
Andreozzi, F; Cascini, GL; Cicone, F; Fiorentino, TV; Miceli, S; Papa, A; Sciacqua, A; Sesti, G; Succurro, E; Veltri, P; Vizza, P1

Trials

4 trial(s) available for glimepiride and fluorodeoxyglucose f18

ArticleYear
Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.
    JACC. Cardiovascular imaging, 2011, Volume: 4, Issue:10

    Topics: Aged; Anti-Inflammatory Agents; Aortic Diseases; Aortography; Biomarkers; Blood Glucose; C-Reactive Protein; Carotid Artery Diseases; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Japan; Male; Middle Aged; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Sulfonylurea Compounds; Thiazolidinediones; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2011
Effects of pioglitazone on visceral fat metabolic activity in impaired glucose tolerance or type 2 diabetes mellitus.
    The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:11

    Topics: Administration, Oral; Aged; Body Fat Distribution; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Humans; Hypoglycemic Agents; Intra-Abdominal Fat; Male; Middle Aged; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Subcutaneous Fat; Sulfonylurea Compounds; Thiazolidinediones; Tomography, X-Ray Computed

2013
Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
    JACC. Cardiovascular imaging, 2013, Volume: 6, Issue:11

    Topics: Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fluorodeoxyglucose F18; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Japan; Male; Middle Aged; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sulfonylurea Compounds; Thiazolidinediones; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2013
Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open-label, crossover, active-comparator FIORE trial.
    Diabetes, obesity & metabolism, 2022, Volume: 24, Issue:12

    Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Glucose; Humans; Sodium-Glucose Transporter 2 Inhibitors

2022

Other Studies

3 other study(ies) available for glimepiride and fluorodeoxyglucose f18

ArticleYear
Imaging inflammatory changes in atherosclerosis multimodal imaging hitting stride.
    JACC. Cardiovascular imaging, 2011, Volume: 4, Issue:10

    Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortic Diseases; Aortography; Atherosclerosis; Carotid Artery Diseases; Contrast Media; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Humans; Hypoglycemic Agents; Inflammation; Magnetic Resonance Angiography; Male; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Sulfonylurea Compounds; Thiazolidinediones; Tomography, X-Ray Computed

2011
Imaging of pharmacologic intervention decoding therapeutic mechanism or defining effectiveness?
    JACC. Cardiovascular imaging, 2011, Volume: 4, Issue:10

    Topics: Anti-Inflammatory Agents; Aortic Diseases; Aortography; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Humans; Hypoglycemic Agents; Inflammation; Male; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Sulfonylurea Compounds; Thiazolidinediones; Tomography, X-Ray Computed

2011
[Effect of glimepiride on the glucose uptake of rat mandibular osteoblasts in hyperglycemia].
    Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology, 2014, Volume: 32, Issue:2

    Topics: Animals; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Hyperglycemia; Mandible; Osteoblasts; Rats; Sulfonylurea Compounds

2014